Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.08.2019 | Case report

Ipilimumab/nivolumab/pembrolizumab

Vitiligo like depigmentation: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

In a case series, three men aged 60-79 years were described who developed vitiligo like depigmentation (VLD) during chemotherapy with ipilimumab, nivolumab and pembrolizumab for nonmelanoma metastatic cancers. …
Literatur
Zurück zum Zitat Liu RC, et al. Vitiligo-like depigmentation in oncology patients treated with immunotherapies for nonmelanoma metastatic cancers. Clinical and Experimental Dermatology 44: 643-646, No. 6, Aug 2019. Available from: URL: http://doi.org/10.1111/ced.13867 - Australia Liu RC, et al. Vitiligo-like depigmentation in oncology patients treated with immunotherapies for nonmelanoma metastatic cancers. Clinical and Experimental Dermatology 44: 643-646, No. 6, Aug 2019. Available from: URL: http://​doi.​org/​10.​1111/​ced.​13867 - Australia
Metadaten
Titel
Ipilimumab/nivolumab/pembrolizumab
Vitiligo like depigmentation: 3 case reports
Publikationsdatum
01.08.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-65961-3

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Methotrexate

Case report

Brimonidine